Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cryptic family protein 1 (CFC1) is an extracellular membrane-associated glycoprotein and a member of the epidermal growth factor (EGF)-Cripto/Frl-1/Cryptic (CFC) protein family. CFC1 serves as a co-receptor for Nodal-related signaling, which is essential for left-right (L-R) patterning during embryonic development and plays a key role in mesoderm and/or neural patterning during gastrulation. Mutations in CFC1 have been strongly linked to congenital heart abnormalities, including visceral heterotaxy and defects in great artery formation. CFC1 is not a common direct therapeutic target or receptor exploited in pharmacology; rather, it is primarily relevant as an essential developmental protein whose mutation causes congenital syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cryptic family protein 1 (CFC1).